ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHIRAPA SINTHUSEK MD

Endocrinology, Diabetes Metabolism

19,459

$1.37M

662
564 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 49%

$70
Average prescription price

Avg: $124

RICHARD DODD M.D.

Endocrinology, Diabetes Metabolism

15,484

$2M

776
546 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 49%

$129
Average prescription price

Avg: $124

MARY LAWRENCE MD

Endocrinology, Diabetes Metabolism

11,678

$869K

501
368 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 49%

$74
Average prescription price

Avg: $124

STEPHEN SOUTH MD

Endocrinology, Diabetes Metabolism

11,427

$832K

583
521 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 49%

$73
Average prescription price

Avg: $124

WALTER KOHUT M.D.

Endocrinology, Diabetes Metabolism

9,969

$815K

390
337 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 49%

$82
Average prescription price

Avg: $124

MARK WARREN M.D.

Endocrinology, Diabetes Metabolism

9,578

$1.2M

499
379 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 49%

$125
Average prescription price

Avg: $124

AJAY KUMAR MD

Endocrinology, Diabetes Metabolism

7,993

$724K

391
274 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 49%

$91
Average prescription price

Avg: $124

SEAN ELLISON M.D.

Endocrinology, Diabetes Metabolism

7,554

$771K

486
335 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 49%

$102
Average prescription price

Avg: $124

DAVID HESTER M.D.

Endocrinology, Diabetes Metabolism

6,624

$910K

583
393 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 49%

$137
Average prescription price

Avg: $124

JEFFREY RUSSELL M.D.

Endocrinology, Diabetes Metabolism

6,604

$1.04M

511
355 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

60%
prescriptions for brand name drugs

Avg: 49%

$157
Average prescription price

Avg: $124

MICHAEL MCGARRITY M.D.

Endocrinology, Diabetes Metabolism

6,225

$882K

574
405 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 49%

$142
Average prescription price

Avg: $124

BRIAN CUMBIE MD

Endocrinology, Diabetes Metabolism

6,027

$798K

448
267 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 49%

$132
Average prescription price

Avg: $124

MICHAEL SOLLENBERGER MD

Endocrinology, Diabetes Metabolism

5,326

$806K

679
493 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 49%

$151
Average prescription price

Avg: $124

PAUL WHITESIDES M.D.

Endocrinology, Diabetes Metabolism

5,131

$623K

507
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 49%

$121
Average prescription price

Avg: $124

NEERAJ ASHRI MD

Endocrinology, Diabetes Metabolism

5,023

$566K

375
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 49%

$113
Average prescription price

Avg: $124

BINDUBAL BALAN M.D.

Endocrinology, Diabetes Metabolism

4,982

$629K

459
325 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 49%

$126
Average prescription price

Avg: $124

DAVID HERMINGHUYSEN MD

Endocrinology, Diabetes Metabolism

4,891

$787K

462
341 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 49%

$161
Average prescription price

Avg: $124

JAMES HOLT MD

Endocrinology, Diabetes Metabolism

4,867

$529K

376
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 49%

$109
Average prescription price

Avg: $124

NILAY DESAI MD

Endocrinology, Diabetes Metabolism

4,857

$785K

657
364 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 49%

$162
Average prescription price

Avg: $124

AUGUSTINE OBI M.D.

Endocrinology, Diabetes Metabolism

4,776

$544K

337
190 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 49%

$114
Average prescription price

Avg: $124

MICHAEL ALTHEIMER M.D.

Endocrinology, Diabetes Metabolism

4,625

$575K

243
199 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 49%

$124
Average prescription price

Avg: $124

DOUGLAS ROBINSON MD

Endocrinology, Diabetes Metabolism

4,490

$518K

391
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 49%

$115
Average prescription price

Avg: $124

CLAUDE ROBEY MD

Endocrinology, Diabetes Metabolism

4,326

$413K

342
247 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 49%

$95
Average prescription price

Avg: $124

ADOLPHUS BONAR M.D.

Endocrinology, Diabetes Metabolism

4,299

$592K

395
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 49%

$138
Average prescription price

Avg: $124

ANALYN TALIP M.D.

Endocrinology, Diabetes Metabolism

4,269

$665K

456
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 49%

$156
Average prescription price

Avg: $124

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank